AET - CVS Health: A Store-Level Look At The Proposed Healthcare Giant
Since about the middle of 2015, investing in CVS Health Corporation (NYSE: CVS) has not been a healthy move for most portfolios. The all-time high of $113.65 hit in July of that year looks positively unreachable now that the stock is trading in the mid-to-high $60's, even after the recent bounce off $60.14. Simply looking at the hard numbers isn't enough to understand the sharp decline in CVS.
Image Source: Yahoo Finance
Image Source: Company 10k
2013 revenues were nearly $127 billion, building to nearly $185 billion in 2017, with year-over-year gains each year in